Alliance Pharma (LON:APH) Reaches New 1-Year High – Should You Buy?

Shares of Alliance Pharma plc (LON:APH) reached a new 52-week high on Tuesday . The company traded as high as GBX 61.60 ($0.77) and last traded at GBX 61.20 ($0.76), with a volume of 5385101 shares changing hands. The stock had previously closed at GBX 61.20 ($0.76).

Wall Street Analyst Weigh In

Separately, Berenberg Bank cut Alliance Pharma to a “hold” rating and cut their target price for the company from GBX 7,000 ($86.93) to GBX 6,250 ($77.62) in a research report on Wednesday.

Alliance Pharma Price Performance

The company has a quick ratio of 1.42, a current ratio of 2.93 and a debt-to-equity ratio of 47.46. The business’s 50-day moving average is GBX 50.26 and its two-hundred day moving average is GBX 44.25. The company has a market capitalization of £330.83 million, a P/E ratio of -1,020.00, a price-to-earnings-growth ratio of 1.04 and a beta of 0.67.

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.